Adial Pharmaceuticals Changes Name to Azora Therapeutics and Names New Executive Team
Stockholders approved conversion of preferred stock issued in the June 2026 acquisition. Azora common stock is set to begin trading on Nasdaq under ticker AZR.
Story updates
08:04:13 PM UTC
SquawkNews
Adial Pharmaceuticals changed its name to Azora Therapeutics and said its stock will begin trading on Nasdaq under AZR on Oct 29, 2026; holders approved conversion of Series A preferred tied to the June 2026 Azora deal.Material DetailsContext by AI AnalystThis is an early-stage repositioning after…
08:28:08 PM UTC
SquawkNews
Azora Therapeutics Common Stk Expected to Begin Trading on Nasdaq Cap Market Under Ticker AZR on Oct 29